McDermott Will & Emery LLP has a large False Claims Act (FCA) defense practice comprised of former federal prosecutors and numerous other lawyers in the Firm’s offices throughout the country who are experienced in defending clients against FCA investigations and qui tam (or “whistleblower”) litigation in courts across the United States. Our deep bench of FCA practitioners represents health care clients, including pharmaceutical manufacturers and a diverse array of healthcare providers, in defending FCA allegations relating to Medicare, Medicaid and other government payors. We also defend many other types of government contractors accused of FCA violations outside the health care context.

Our FCA lawyers have substantial experience obtaining declinations, negotiating favorable resolutions with the Department of Justice, state attorneys general, and the Office of the Inspector General, as well as obtaining successful in-court results in FCA cases that proceed to litigation. In addition to representing clients in investigations and litigation, we regularly advise clients in connection with developing and improving internal mechanisms to enhance compliance and minimize FCA risk.

The volume of False Claims Act investigations and litigation continues to rise at a rapid pace. We have designed this blog to share our observations and insights regarding the most recent developments in this evolving area of the law. We hope you find the blog to be both interesting and helpful and we welcome your feedback. If you have questions or topic suggestions, please let us know via the “Contact” form or feel free to reach out to one of the editors directly.